For example, several studies emphasize the role of different molecules such as vascular endothelial growth factor proteins (VEGF), matrix metalloproteinases (MMP-2 and 9), and tumor-related tissue inhibitory metalloproteinases (TIMPs) that express higher serum values in patients with early-stage melanoma [52,53]. The gene discussed is VEGFA; the disease is melanoma.